Article Tools

Search for Related Articles

  • By Author
  • Search In

Announcements

CID LISTED AMONG
“MOST INFLUENTIAL”

Clinical Infectious Diseases has been named as one of the "100 Most Influential Journals in Biology and Medicine" of the past 100 years by the Special Libraries Association. The list was compiled by the 680-plus members of SLA’s Biomedical and Life Sciences Division.

See the full list here.

Source: The DBIO 100, the 100 Most Influential Journals in Biology & Medicine over the last 100 Years

In the News

Featured in MSNBC
"Germs and flu are up; infection control is down" June 9, 2009
Trends in the Incidence of Methicillin‐Resistant Staphylococcus aureus Infection in Children’s Hospitals in the United States
Jeffrey S. Gerber, Susan E. Coffin, Sarah A. Smathers, and Theoklis E. Zaoutis
Just this week, researchers reported that the incidence of MRSA infections among children admitted to pediatric hospitals in the United States more than tripled between 2002 and 2007. Researchers at the Children’s Hospital of Philadelphia and the University of Pennsylvania found cases of MRSA jumped from 6.7 per 1,000 admissions in 2002 to 21.1 cases per 1,000 admissions in 2007, according to a study released online Monday in the journal Clinical Infectious Diseases.

Featured in Toronto Star
"Pigs, viruses and politics" May 2, 2009
Are Swine Workers in the United States at Increased Risk of Infection with Zoonotic Influenza Virus?
Kendall P. Myers, Christopher W. Olsen, Sharon F. Setterquist, Ana W. Capuano, Kelley J. Donham, Eileen L. Thacker, James A. Merchant, and Gregory C. Gray
Another study, this one published in the U.S. journal Clinical Infectious Diseases in 2006, found that workers in meat-processing plants have a greater likelihood of being infected by some version of the H1N1 flu virus than the general population (the odds of pig farmers getting the disease are significantly greater again).

Featured in Philadelphia Inquirer
"A shot in the arm for vaccines" April 19, 2009
Vaccines: Pneumococcal Vaccination of Elderly Adults: New Paradigms for Protection
Lisa A. Jackson and Edward N. Janoff
Every year, an estimated 915,000 people 65 and older get pneumonia, and 40 percent of them end up in hospitals, according to a 2004 paper in the journal Clinical Infectious Diseases. Pneumonia often kills older people, said Richard Stefanacci, a geriatrician at the University of the Sciences in Philadelphia.

15 March 2008 Supplement

Volume 46, Number S3
Clinical Infectious Diseases 2008;46:S195–S203
1058-4838/2008/4606S3-0006$15.00
DOI: 10.1086/524383
SUPPLEMENT ARTICLE

Performance of an Algorithm for Assessing Smallpox Risk among Patients with Rashes That May Be Confused with Smallpox

Sonja S. Hutchins,1

Iddrisu Sulemana,1

Katherine L. Heilpern,3

William Schaffner,4

Gary Wax,8

E. Brooke Lerner,9

Barbara Watson,10

Robert Baltimore,13

Rachel A. Waltenburg,3

Dominik Aronsky,5,6

Susan Coffin,11

Gladys Ng,13

Allen S. Craig,7

Amy Behrman,12

James Meek,13

Eileen Sherman,10

Sandra S. Chavez,1

Rafael Harpaz,1 and

Scott Schmid2

1National Immunization Program and 2National Center for Infectious Diseases, Centers for Disease Control and Prevention, and 3Emory University, Atlanta, Georgia; Departments of 4Preventive Medicine, 5Biomedical Informatics, and 6Emergency Medicine, Vanderbilt University School of Medicine, and 7Tennessee Department of Health, Nashville, Tennessee; 8Minnesota Department of Health, St. Paul; 9Department of Emergency Medicine, University of Rochester, Rochester, New York; 10Division for Disease Control, City of Philadelphia Department of Health, 11Division of Infectious Diseases, Children’s Hospital of Philadelphia, and 12Department of Emergency Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania; and 13Connecticut Emerging Infections Program, Yale University School of Medicine, New Haven

After the 2001 anthrax bioterror attacks, the Centers for Disease Control and Prevention developed an algorithm to evaluate patients rapidly for suspected smallpox. A prospective, multicenter study examined the performance of this algorithm in assessing patients with an acute, generalized vesicular or pustular rash (AGVPR) admitted to emergency departments and inpatient units of 12 acute‐care hospitals in 6 states. Of 26,747 patients (3.5% of all admissions) with rashlike conditions screened, 89 (1.2 patients per 10,000 admissions) had an AGVPR. Physicians or study staff classified none of 73 enrolled patients as being at high risk for having smallpox; 72 (99%) were classified as being at low risk, and 1 was classified as being at moderate risk. The discharge diagnosis for 55 (75%) of these 73 participants was varicella illness. Use of the algorithm did not result in misclassification of AGVPR as high risk for smallpox. The algorithm is a highly specific tool for clinical evaluation of suspected smallpox disease.

Reprints or correspondence: Dr. Sonja S. Hutchins, Office of Minority Health and Health Disparities, Centers for Disease Control and Prevention, MS E‐67, 1600 Clifton Rd. NE, Atlanta, GA 30333 ().

Cited by

Raymond A. Strikas, Linda J. Neff, Lisa Rotz, Joanne Cono, Donna Knutson, Joseph Henderson, and Walter A. Orenstein. (2008) US Civilian Smallpox Preparedness and Response Program, 2003. Clinical Infectious Diseases 46:s3, S157-S167
Online publication date: 15-Mar-2008.
Louisa E. Chapman, Gina T. Mootrey, and Linda J. Neff. (2008) Introduction: Vaccination against Smallpox in the Posteradication Era. Clinical Infectious Diseases 46:s3, S153-S156
Online publication date: 15-Mar-2008.
Sonja S. Hutchins, Guthrie S. Birkhead, Kristin Kenyan, John Abellera, Jennifer Lemmings, and the Council of State and Territorial Epidemiologists Smallpox Working Group. (2008) Public Health Surveillance for Suspected Smallpox in the United States, 2003–2005: Results of a National Survey. Clinical Infectious Diseases 46:s3, S204-S211
Online publication date: 15-Mar-2008.
  • The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the funding agency.

Close Popup